Relationship Between Bi-Caudate Ratio and White Matter Atrophy in Brain MRI of Multiple Sclerosis
Novelty in Biomedicine,
Vol. 13 No. 1 (2025),
20 January 2025
,
Page 22-27
https://doi.org/10.22037/nbm.v13i1.46231
Abstract
Background: Multiple sclerosis (MS) is one of the most common and debilitating neurological diseases. Brain magnetic resonance imaging (MRI) is critical to determine the prognosis of MS. Using simple and accessible techniques is one of the researchers' concerns. So far, limited studies have been conducted on evaluating the relationship between the Bi-caudate ratio (BCR) and white matter atrophy in brain MRI of patients with MS. Therefore, in this study, we decided to evaluate this relationship.
Materials and Methods: In this cross-sectional study, which was conducted to determine the relationship between BCR and white matter atrophy in brain MRI patients with MS, patients with MS who were evaluated by MRI at Imam Hossein Hospital (Tehran-Iran) in 2022 were assessed. BCR is determined by dividing the shortest distance between two caudate nuclei by the length of the brain at the imaging. The symbol digit modalities test (SDMT) was used to check the cognitive function of patients, and the relationship between BCR and MS-related parameters was evaluated. Expanded disability status score (EDSS) was also evaluated. A significance level was considered less than 0.05.
Results: Eighty-five patients with a mean age of 40.73 ± 8.45 years and female gender was more prevalent (65.9%). The mean EDSS in all participants was 2.64 ± 2.49, and the mean BCR was 0.11 ± 0.03. EDSS score, age of the disease onset, SDMT score, and BCR were significantly different between different MS types (secondary progressive MS, primary progressive MS, and relapsing-remitting MS) (P-values<0.05). There was a statistically significant relationship between age, disease duration, EDSS score, onset age of the disease, and SDMT score with BCR (P<0.05). There was a statistically significant difference in the amount of BCR between sexes (P<0.045).
Conclusion: BCR is a valuable method for evaluating the condition of multiple sclerosis, and it can be used as a simple and accessible technique for evaluating MS conditions.
- Atrophy
- Multiple sclerosis
- White matter
- Magnetic resonance imaging
How to Cite
References
Koriem KMM. Multiple sclerosis: New insights and trends. Asian Pacific Journal of Tropical Biomedicine. 2016;6(5):429-40.
Loma I, Heyman R. Multiple sclerosis: pathogenesis and treatment. Current neuropharmacology. 2011;9(3):409-16.
Filippi M, Preziosa P, Banwell BL, Barkhof F, Ciccarelli O, De Stefano N, et al. Assessment of lesions on magnetic resonance imaging in multiple sclerosis: practical guidelines. Brain. 2019;142(7):1858-75.
Weidauer S, Raab P, Hattingen E. Diagnostic approach in multiple sclerosis with MRI: an update. Clinical Imaging. 2021;78:276-85.
Ceccarelli A, Bakshi R, Neema M. MRI in multiple sclerosis: a review of the current literature. Current opinion in neurology. 2012;25(4):402-9.
Giorgio A, De Stefano N. Effective utilization of MRI in the diagnosis and management of multiple sclerosis. Neurologic clinics. 2018;36(1):27-34.
Margoni M, Pagani E, Meani A, Storelli L, Mesaros S, Drulovic J, et al. Exploring in vivo multiple sclerosis brain microstructural damage through T1w/T2w ratio: a multicentre study. Journal of Neurology, Neurosurgery & Psychiatry. 2022;93(7):741-52.
Cooper G, Finke C, Chien C, Brandt AU, Asseyer S, Ruprecht K, et al. Standardization of T1w/T2w ratio improves detection of tissue damage in multiple sclerosis. Frontiers in neurology. 2019;10:334.
Kister I, Chamot E, Salter AR, Cutter GR, Bacon TE, Herbert J. Disability in multiple sclerosis: a reference for patients and clinicians. Neurology. 2013;80(11):1018-24.
Bagnato F, Gauthier SA, Laule C, Moore GRW, Bove R, Cai Z, et al. Imaging mechanisms of disease progression in multiple sclerosis: beyond brain atrophy. Journal of Neuroimaging. 2020;30(3):251-66.
Marciniewicz E, Podgórski P, Sąsiadek M, Bladowska J. The role of MR volumetry in brain atrophy assessment in multiple sclerosis: A review of the literature. Advances in Clinical & Experimental Medicine. 2019;28(7).
Storelli L, Rocca MA, Pagani E, Van Hecke W, Horsfield MA, De Stefano N, et al. Measurement of whole-brain and gray matter atrophy in multiple sclerosis: assessment with MR imaging. Radiology. 2018;288(2):554-64.
Popescu V, Klaver R, Voorn P, Galis-de Graaf Y, Knol D, Twisk J, et al. What drives MRI-measured cortical atrophy in multiple sclerosis? Multiple Sclerosis Journal. 2015;21(10):1280-90.
Wattjes M, Steenwijk M, Stangel M. MRI in the diagnosis and monitoring of multiple sclerosis: an update. Clinical neuroradiology. 2015;25:157-65.
Granziera C, Wuerfel J, Barkhof F, Calabrese M, De Stefano N, Enzinger C, et al. Quantitative magnetic resonance imaging towards clinical application in multiple sclerosis. Brain. 2021;144(5):1296-311.
Serag D, Ragab E. Bi-caudate ratio as a MRI marker of white matter atrophy in multiple sclerosis and ischemic leukocencephalopathy. Egyptian Journal of Radiology and Nuclear Medicine. 2019;50:1-6.
Oset M, Domowicz M, Wildner P, Siger M, Karlińska I, Stasiołek M, Świderek-Matysiak M. Predictive value of brain atrophy, serum biomarkers and information processing speed for early disease progression in multiple sclerosis. Frontiers in Neurology. 2023;14:1223220.
Hestad K, McArthur J, Pan GD, Selnes O, Nance‐Sproson T, Aylward E, et al. Regional brain atrophy in HIV‐1 infection: association with specific neuropsychological test performance. Acta Neurologica Scandinavica. 1993;88(2):112-8.
Leach JM, Cutter G, Golan D, Doniger G, Zarif M, Bumstead B, et al. Measuring cognitive function by the SDMT across functional domains: Useful but not sufficient. Multiple Sclerosis and Related Disorders. 2022;60:103704.
Noseworthy J, Vandervoort M, Wong C, Ebers G. Interrater variability with the Expanded Disability Status Scale (EDSS) and Functional Systems (FS) in a multiple sclerosis clinical trial. Neurology. 1990;40(6):971-.
Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology. 1983;33(11):1444-.
Kurtzke J. Origin of DSS: to present the plan. Multiple Sclerosis Journal. 2007;13(1):120-3.
Altokhis A, Alotaibi A, Morgan P, Tanasescu R, Evangelou N. Predictors of long-term disability in multiple sclerosis patients using routine magnetic resonance imaging data: A 15-year retrospective study. The Neuroradiology Journal. 2023;36(5):524-32.
Milovanovic N, Damjanovic A, Milovanovic S, Duisin D, Malis M, Stankovic G, et al. Reliability of the bicaudate parameter in the revealing of the enlarged lateral Ventricles in schizophrenia patients. Psychiatria Danubina. 2018;30(2):150-6.
- Abstract Viewed: 45 times
- pdf Downloaded: 37 times